Rapid Practice Points Developed for RSV Vaccines in Adults

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Amazon Big Spring Sale - Up to 40% off

Medically reviewed by Carmen Pope, BPharm. Last updated on March 5, 2026.

via HealthDay

THURSDAY, March 5, 2026 -- In a clinical guideline issued by the American College of Physicians and published online March 2 in the Annals of Internal Medicine, rapid practice points are presented for receipt of respiratory syncytial virus (RSV) protein subunit vaccines among adults.

Isabel T.K. Moser, M.D., from the University for Continuing Education Krems in Austria, and colleagues analyzed the efficacy, comparative effectiveness, and harm of RSV vaccines in nonpregnant adults who are not immunocompromised in a review involving seven randomized controlled trials (RCTs) and one nonrandomized study. The researchers found that RSV protein subunit vaccines probably reduce RSV-related hospitalization (vaccine efficacy, 83.3 percent) and severe RSV illness (vaccine efficacy, 94.1 percent) in older adults (60 years and older), but have no effect on all-cause mortality risk. In terms of serious adverse events, the investigators note that they probably do not differ from placebo or no vaccination.

Amir Qaseem, M.D., Ph.D., from the American College of Physicians in Philadelphia, and colleagues developed rapid practice points for RSV vaccines in adults aged 18 years and older who are not immunocompromised. According to the practice points, adults aged 75 years or older should receive an RSV protein subunit vaccine. Receipt of an RSV protein subunit vaccine can be considered among adults aged 60 to 74 years who have an increased risk for severe RSV.

"There is a need for additional RCTs in adults with and without increased risk for severe RSV that evaluate clinical benefits, such as all-cause mortality and RSV-related hospitalization, and harms," Qaseem and colleagues write.

Abstract/Full Text - Review (subscription or payment may be required)

Abstract/Full Text - Clinical Guideline

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-06 02:13

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords